Online citations, reference lists, and bibliographies.
Referencing for people who value simplicity, privacy, and speed.
Get Citationsy
← Back to Search

A Comprehensive Overview On Osteoporosis And Its Risk Factors

F. Pouresmaeili, B. Kamalidehghan, M. Kamarehei, Y. Goh
Published 2018 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
Osteoporosis is a bone disorder with remarkable changes in bone biologic material and consequent bone structural distraction, affecting millions of people around the world from different ethnic groups. Bone fragility is the worse outcome of the disease, which needs long term therapy and medical management, especially in the elderly. Many involved genes including environmental factors have been introduced as the disease risk factors so far, of which genes should be considered as effective early diagnosis biomarkers, especially for the individuals from high-risk families. In this review, a number of important criteria involved in osteoporosis are addressed and discussed.
This paper references
10.1093/OXFORDJOURNALS.AJE.A115204
Epidemiology of vertebral fractures in women.
L. J. Melton (1989)
10.1016/j.bone.2013.04.021
Genetic polymorphism at Val80 (rs700518) of the CYP19A1 gene is associated with aromatase inhibitor associated bone loss in women with ER + breast cancer.
N. Napoli (2013)
10.1007/s10165-008-0032-5
Characteristics of fracture and related factors in patients with rheumatoid arthritis
A. Nampei (2008)
Proper Calcium Use: Vitamin K2 as a Promoter of Bone and Cardiovascular Health.
K. Maresz (2015)
Gene-environment interactions in the skeletal response to nutrition and exercise during growth. Optimizing Bone Mass and Strength
JP Bonjour (2007)
Vitamin D receptor 3 ′ - untranslated region polymorphisms : lack of effect on mRNA stabil
LK Durrin (2008)
10.1210/JC.2002-021813
Association between an insulin-like growth factor I gene promoter polymorphism and bone mineral density in the elderly: the Rotterdam Study.
F. Rivadeneira (2003)
10.1677/JME-08-0003
Tumour necrosis factor superfamily member 11 gene promoter polymorphisms modulate promoter activity and influence bone mineral density in postmenopausal women with osteoporosis.
Simona Mencej (2008)
10.1007/s001980170010
Association of a G2014A Transition in Exon 8 of the Estrogen Receptor-α Gene with Postmenopausal Osteoporosis
B. Ongphiphadhanakul (2001)
Gla protein , estrogen receptor 1 , collagen 1 - A 1 and calcitonin receptor genes in Turkish postmenopausal women
T Hosoi (2013)
10.1097/00019616-199905000-00016
Smoking increases bone loss and decreases intestinal calcium absorption.
E. Krall (1999)
10.1359/jbmr.2002.17.10.1744
Klotho Gene Polymorphisms Associated With Bone Density of Aged Postmenopausal Women
K. Kawano (2002)
10.1359/jbmr.1998.13.4.695
Bone Mineral Density and Its Change in White Women: Estrogen and Vitamin D Receptor Genotypes and Their Interaction
M. Willing (1998)
10.1359/jbmr.2002.17.4.716
Incidence of Vertebral Fracture in Europe: Results From the European Prospective Osteoporosis Study (EPOS)
D. Felsenberg (2002)
Amyloid β-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer’s disease brain. A review
DA Butterfield (2002)
10.1126/SCIENCE.289.5484.1504
Bone resorption by osteoclasts.
S. Teitelbaum (2000)
10.2174/157339910791162970
Bone disease in diabetes.
M. L. Isidro (2010)
Alzheimer's disease and osteoporosis: common risk factors or one condition predisposing to the other?
Marzena Tysiewicz-Dudek (2008)
Current concepts in the management of distal radius fractures.
E. Shin (2007)
10.1016/S0140-6736(17)32137-2
Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial
D. Kendler (2018)
10.1359/jbmr.2001.16.7.1256
The Polymorphism in the Caudal‐Related Homeodomain Protein Cdx‐2 Binding Element in the Human Vitamin D Receptor Gene
H. Arai (2001)
10.1002/jbmr.32
Osteocalcin gene polymorphisms influence concentration of serum osteocalcin and enhance fracture identification
Fiona Mcguigan (2010)
10.1359/jbmr.1997.12.11.1769
The Prevalence of Osteoporosis
L. J. Melton (1997)
10.1007/s11914-014-0248-6
Lifestyle and Osteoporosis
K. Zhu (2014)
10.1186/1471-2474-8-48
Incidence and characteristics of distal radius fractures in a southern Swedish region
E. Brogren (2007)
The impact of incident vertebral and non-vertebral fragility fractures on health-related quality of life in established postmenopausal osteoporosis: results from the teriparatide randomized, placebo-controlled trial in postmenopausal women.
A. Oglesby (2003)
10.1016/0002-9343(79)90640-5
Vitamin D metabolism and calcium absorption.
A. Norman (1979)
10.1038/nm1593
Skeletal remodeling in health and disease
M. Zaidi (2007)
10.17226/5776
Intakes for Calcium , Phosphorus , Magnesium , Vitamin D , and Fluoride
(1974)
10.1016/S0025-6196(11)60752-0
Adverse effects of bisphosphonates: implications for osteoporosis management.
K. Kennel (2009)
10.1016/S0140-6736(77)92562-4
RELATION BETWEEN SMOKING AND AGE OF NATURAL MENOPAUSE: Report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center
H. Jick (1977)
10.1210/JCEM.87.4.8419
Association between AAAG repeat polymorphism in the P3 promoter of the human parathyroid hormone (PTH)/PTH-related peptide receptor gene and adult height, urinary pyridinoline excretion, and promoter activity.
M. Minagawa (2002)
10.1155/2012/639469
Fisetin Inhibits Hyperglycemia-Induced Proinflammatory Cytokine Production by Epigenetic Mechanisms
H. J. Kim (2012)
10.1016/j.jaci.2013.08.040
Glucocorticoid-induced osteoporosis: an update on effects and management.
B. Buehring (2013)
10.1016/S1043-2760(98)00065-4
The Vitamin D Receptor Gene and Calcium Metabolism
S. Ferrari (1998)
The prevalence and risk factors of osteoporosis among a Saudi female diabetic population. Open Access Maced
Al-Homood Ia Sheshah (2017)
10.1359/jbmr.2002.17.8.1527
Alleles of RUNX2/CBFA1 Gene Are Associated With Differences in Bone Mineral Density and Risk of Fracture
T. Vaughan (2002)
10.1359/jbmr.091035
Odanacatib, a cathepsin‐K inhibitor for osteoporosis: A two‐year study in postmenopausal women with low bone density
H. Bone (2010)
10.3275/8646
Phalangeal quantitative ultrasound and metabolic control in pre-menopausal women with Type 1 diabetes mellitus
Antonino Catalano (2012)
10.1359/jbmr.1999.14.10.1796
Vertebral Bone Mass, Size, and Volumetric Density in Women with Spinal Fractures
Y. Duan (1999)
Calcitonin receptor olymorphism is associated with a decreased fracture risk in post-menopausal women
J Taboulet (1998)
10.1210/EN.2004-1677
Increased bone adiposity and peroxisomal proliferator-activated receptor-gamma2 expression in type I diabetic mice.
Sergiu Botolin (2005)
10.1007/s007740170013
A polymorphic variant at the Werner helicase (WRN) gene is associated with bone density, but not spondylosis, in postmenopausal women
N. Ogata (2001)
10.7326/0003-4819-128-10-199805150-00001
The Association of Radiographically Detected Vertebral Fractures with Back Pain and Function: A Prospective Study
M. Nevitt (1998)
10.1016/1043-4666(92)90041-O
Cloning and chromosome mapping of the human interleukin-1 receptor antagonist gene.
A. Lennard (1992)
10.1080/02701367.1994.10607620
1994 C. H. McCloy Research Lecture: does physical activity play a role in preventing osteoporosis?
B. Drinkwater (1994)
10.1016/S8756-3282(02)00971-7
Polymorphisms in the transforming growth factor beta 1 gene and osteoporosis.
B. Langdahl (2003)
10.1002/JBMR.5650090614
Analysis of gene expression in human bone biopsies by polymerase chain reaction: Evidence for enhanced cytokine expression in postmenopausal osteoporosis
S. Ralston (1994)
10.1016/j.jalz.2009.04.1088
Hip fracture risk and subsequent mortality among Alzheimer's disease patients in the United Kingdom, 1988-2007
N. Baker (2009)
10.1359/jbmr.1998.13.3.325
The Nuclear Vitamin D Receptor: Biological and Molecular Regulatory Properties Revealed
M. R. Haussler (1998)
10.1007/s001090100190
Association of the C–509→T polymorphism, alone or in combination with the T869→C polymorphism, of the transforming growth factor-β1 gene with bone mineral density and genetic susceptibility to osteoporosis in Japanese women
Y. Yamada (2001)
10.1210/JCEM.83.3.4649
Vitamin D and estrogen receptor allelic variants in Italian postmenopausal women: evidence of multiple gene contribution to bone mineral density.
L. Gennari (1998)
10.1097/BCO.0B013E3282630851
The role of alkaline phosphatase in mineralization
E. Golub (2007)
10.1111/J.1399-0039.2007.00833.X
HLA alleles as predisposal factors for postmenopausal osteoporosis in a Greek population.
K. Douroudis (2007)
10.1136/ard.54.10.801
Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis.
N. Peel (1995)
Physician’s Guide to Prevention and Treatment of Osteoporosis
B Dawson-Hughes (2003)
Fracture Study. Incidence of distal forearm fracture in British men and women
T O’neill (2001)
10.3889/oamjms.2017.030
The Prevalence and Risk Factors of Osteoporosis among a Saudi Female Diabetic Population
I. Al-Homood (2017)
10.3109/17453678508994354
Epidemiology of distal radius fractures.
S. Solgaard (1985)
10.1016/S0039-6060(97)90357-3
Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women.
E. Lundgren (1997)
10.3390/sports5020029
Exercise, Osteoporosis, and Bone Geometry
A. Harding (2017)
10.1038/79216
The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
D. Altshuler (2000)
10.1016/J.BONE.2007.03.017
Molecular and cellular mechanisms of the anabolic effect of intermittent PTH.
R. Jilka (2007)
10.1001/JAMA.292.17.2105
Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomes.
J. Ioannidis (2004)
10.1159/000103007
Risk factors for fractures in normally active children and adolescents.
A. Goulding (2007)
10.1016/J.YGCEN.2007.11.003
Calcium homeostasis: reassessment of the actions of parathyroid hormone.
R. Talmage (2008)
10.1073/pnas.0808701106
Dissociation of the neuronal regulation of bone mass and energy metabolism by leptin in vivo
Y. Shi (2008)
10.1001/JAMA.285.3.320
Risk of new vertebral fracture in the year following a fracture.
R. Lindsay (2001)
10.1210/EDRV-13-4-719
Newly identified actions of the vitamin D endocrine system.
M. R. Walters (1992)
10.1038/nature03398
Leptin regulation of bone resorption by the sympathetic nervous system and CART
F. Elefteriou (2005)
10.1186/ar2167
Role of RANKL inhibition in osteoporosis
M. Mcclung (2007)
10.1210/en.2008-0817
The pairing of a selective estrogen receptor modulator, bazedoxifene, with conjugated estrogens as a new paradigm for the treatment of menopausal symptoms and osteoporosis prevention.
Y. Kharode (2008)
10.1007/s00198-003-1454-8
A theoretical analysis of the relative influences of peak BMD, age-related bone loss and menopause on the development of osteoporosis
C. Hernandez (2003)
Development panel on osteoporosis: prevention, diagnosis and therapy
N. Consensus (2001)
Osteoporosis and its Association with Estrogen Receptor- alpha Gene Polymorphism in a population of Iranian Women Referring to Loghman Hospital
Pouresmaeili Farkhondeh (2009)
Estrogen receptor β gene polymorphisms are associated with higher
H Lau (2000)
Insulin-Like Growth Factor-I in Men with Idiopathic Osteoporosis 1
ES Kurland (1997)
10.1007/BF02499881
The epidemiology of vertebral fractures
A. Silman (2006)
10.1359/jbmr.1999.14.2.240
The Caudal‐Related Homeodomain Protein Cdx‐2 Regulates Vitamin D Receptor Gene Expression in the Small Intestine
H. Yamamoto (1999)
10.1073/PNAS.97.10.5474
Estrogen receptor specificity in the regulation of skeletal growth and maturation in male mice.
O. Vidal (2000)
10.1016/j.maturitas.2016.07.010
Smoking, alcohol and caffeine in relation to two hormonal indicators of ovarian age during the reproductive years.
J. Kline (2016)
10.1007/s00198-011-1636-8
Undertreatment of osteoporosis in persons with dementia? A population-based study
Y. Haasum (2011)
10.1038/sj.ejcn.1600870
The influence of smoking on vitamin D status and calcium metabolism
C. Brot (1999)
The impact of diabetes mellitus on skeletal health: an established phenomenon with inestablished causes?
I. Raška (2005)
10.1016/J.MATURITAS.2006.01.003
Vitamin D receptor gene polymorphisms and bone mineral density in postmenopausal Indian women.
Sumegha Mitra (2006)
10.1172/JCI484
Synovium as a source of increased amino-terminal parathyroid hormone-related protein expression in rheumatoid arthritis. A possible role for locally produced parathyroid hormone-related protein in the pathogenesis of rheumatoid arthritis.
J. Funk (1998)
10.1006/BBRC.1998.8880
Polymorphisms of the calcitonin receptor gene are associated with bone mineral density in postmenopausal Italian women.
L. Masi (1998)
Scanning electron microscopy in bone pathology: review of methods, potential and applications.
A. Boyde (1986)
10.1172/JCI113885
Insulin-like growth factor I mediates selective anabolic effects of parathyroid hormone in bone cultures.
E. Canalis (1989)
10.1016/S8756-3282(02)00827-X
Estrogen receptor beta gene polymorphisms are associated with higher bone mineral density in premenopausal, but not postmenopausal southern Chinese women.
H. Lau (2002)
10.1177/1071557600007001S06
Estrogen Receptor Knock-Out Mice: Molecular and Endocrine Phenotypes
K. Korach (2000)
[Osteoporosis in diabetes].
Y. Kumeda (2008)
10.1359/JBMR.050717
Polymorphisms of the CLCN7 Gene Are Associated With BMD in Women
U. Pettersson (2005)
10.1007/s00198-009-0956-4
Polymorphisms and haplotypes across the osteoprotegerin gene associated with bone mineral density and osteoporotic fractures
S. Jurado (2009)
10.1007/s11999-010-1736-3
Gender and Race/Ethnicity Differences in Hip Fracture Incidence, Morbidity, Mortality, and Function
R. Sterling (2011)
10.1016/S0968-0004(01)01995-8
The molecular architecture of the TNF superfamily.
Jean-Luc Bodmer (2002)
10.1016/j.jocd.2008.04.003
National Osteoporosis Foundation 2008 Clinician's Guide to Prevention and Treatment of Osteoporosis and the World Health Organization Fracture Risk Assessment Tool (FRAX): what they mean to the bone densitometrist and bone technologist.
N. Watts (2008)
10.1055/S-2001-18605
Diabetes mellitus a risk for osteoporosis?
G. Leidig-Bruckner (2001)
10.1097/00005768-200106001-00026
Dose-response of physical activity and low back pain, osteoarthritis, and osteoporosis.
I. Vuori (2001)
Vitamin D–Receptor Gene Polymorphisms and Bone Density in Prepubertal American Girls of Mexican Descent
An (2000)
10.1007/S11914-005-0017-7
Mechanisms of glucocorticoid action in bone
E. Canalis (2002)
10.1111/j.1532-5415.1999.tb07436.x
APOE 4 and Hip Fracture Risk in a Community‐Based Study of Older Adults
J. M. Johnston (1999)
10.1001/JAMA.285.6.785
Osteoporosis prevention, diagnosis, and therapy.
A. Klibanski (2001)
10.1007/s00198-012-1964-3
A systematic review of hip fracture incidence and probability of fracture worldwide
J. Kanis (2012)
10.1359/jbmr.1998.13.1.96
High Fatty Acid Content in Rabbit Serum Is Responsible for the Differentiation of Osteoblasts Into Adipocyte‐like Cells
D. D. Diascro (1998)
Association between Vitamin D Receptor Gene BsmI Polymorphism and Bone Mineral Density in A Population of 146 Iranian Women
F. Pouresmaeili (2013)
10.1093/AJE/KWH287
CYP17 gene polymorphisms: prevalence and associations with hormone levels and related factors. a HuGE review.
L. Sharp (2004)
10.1681/ASN.2008101059
Dickkopf-1 promotes hyperglycemia-induced accumulation of mesangial matrix and renal dysfunction.
Chun-Liang Lin (2010)
10.1007/s00394-012-0480-8
A prospective study of plasma vitamin D metabolites, vitamin D receptor gene polymorphisms, and risk of hypertension in men
L. Wang (2012)
10.1111/J.1753-4887.1991.TB03013.X
The meaning and measurement of lean body mass.
R. Roubenoff (1991)
10.1210/JCEM.86.1.7139
Older women with diabetes have an increased risk of fracture: a prospective study.
A. Schwartz (2001)
10.1677/JOE.0.1770147
Molecular studies of identification of genes for osteoporosis: the 2002 update.
Yao-zhong Liu (2003)
10.1055/s-2008-1046793
Association of the 163A/G and 1181G/C osteoprotegerin polymorphism with bone mineral density.
M. T. García-Unzueta (2008)
Group EVOS. The epidemiology of vertebral fractures
C Cooper (1993)
10.1093/RHEUMATOLOGY/31.12.801
Localization of interleukin-1 alpha, type 1 interleukin-1 receptor and interleukin-1 receptor antagonist in the synovial membrane and cartilage/pannus junction in rheumatoid arthritis.
B. Deleuran (1992)
10.1001/ARCHINTE.1990.00390180133024
Relationship between forearm and vertebral mineral density in postmenopausal women with primary hyperparathyroidism.
J. Wishart (1990)
10.1093/RHEUMATOLOGY/31.10.653
Detection of cytokines at the cartilage/pannus junction in patients with rheumatoid arthritis: implications for the role of cytokines in cartilage destruction and repair.
C. Chu (1992)
10.1097/01.JU.0000143930.73016.C6
Hip fractures in men with prostate cancer treated with orchiectomy.
P. Dickman (2004)
10.1111/j.1399-0004.2006.00703.x
Association of the CT gene (CA) polymorphism with BMD in osteoporotic mexican women
J. J. Magaña (2006)
10.1128/MCB.14.9.6317
Introns are cis effectors of the nonsense-codon-mediated reduction in nuclear mRNA abundance.
J. Cheng (1994)
10.1007/s11010-009-0344-6
High glucose stimulates adipogenic and inhibits osteogenic differentiation in MG-63 cells through cAMP/protein kinase A/extracellular signal-regulated kinase pathway
W. Wang (2009)
10.1007/s00774-005-0657-9
Risk factors for vertebral fracture in menopausal or postmenopausal Japanese women with rheumatoid arthritis: a cross-sectional and longitudinal study
K. Arai (2005)
10.1056/NEJM199709043371003
Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older.
B. Dawson-Hughes (1997)
10.1080/1071576021000049890
Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review.
D. Butterfield (2002)
Pharmacokinetics/pharmacodynamics of bisphosphonates: use for optimisation of intermittent therapy for osteoporosis
SC Cremers (2005)
Birth and death of bone cells : basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis 1
SC Manolagas (2000)
10.7326/0003-4819-152-6-201003160-00008
Meta-analysis: Excess Mortality After Hip Fracture Among Older Women and Men
P. Haentjens (2010)
10.1007/s00198-015-3222-y
Trabecular bone score in type 1 diabetes—a cross-sectional study
T. Neumann (2015)
10.1053/berh.2002.0264
The epidemiology of osteoporosis.
E. Dennison (1996)
10.1073/PNAS.95.4.1387
Parathyroid hormone activation of the 25-hydroxyvitamin D3-1alpha-hydroxylase gene promoter.
H. Brenza (1998)
10.1016/J.BBRC.2005.01.117
Glucocorticoid suppresses the canonical Wnt signal in cultured human osteoblasts.
K. Ohnaka (2005)
10.1007/s002239900462
Bone Mineral Density and Bone Size in Men With Primary Osteoporosis and Vertebral Fractures
E. Vega (1998)
10.1016/S0960-0760(01)00069-3
Codon 325 sequence polymorphism of the estrogen receptor α gene and bone mineral density in postmenopausal women
Sanja Jurada (2001)
The exercise intervention may influence the dietary intake and reduce the risk of osteoporosis and sarcopenia in menopausal women
P Yang (2017)
10.1097/00002281-199206000-00019
Epidemiology, etiology, and diagnosis of osteoporosis.
M. Audran (1992)
10.1136/bmj.321.7261.598
Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism
P. Vestergaard (2000)
10.1002/JBMR.5650060404
Smoking and bone loss among postmenopausal women
E. Krall (1991)
10.1359/jbmr.0301205
Characterization of Common Genetic Variants in Cathepsin K and Testing for Association With Bone Mineral Density in a Large Cohort of Perimenopausal Women From Scotland
Fabienne S. Giraudeau (2004)
10.1007/s100380070006
Association of bone mineral density with a dinucleotide repeat polymorphism at the calcitonin (CT) locus
M. Miyao (2000)
10.1093/AJE/KWI055
Estrogen receptor gene polymorphisms and the genetics of osteoporosis: a HuGE review.
L. Gennari (2005)
10.1186/1471-2172-13-19
High glucose concentrations induce TNF-α production through the down-regulation of CD33 in primary human monocytes
Yolanda Gonzalez (2011)
10.1359/JBMR.051013
Association of Functionally Different RUNX2 P2 Promoter Alleles With BMD
J. Doecke (2006)
10.1001/archneur.65.10.1348
Prevalence of vitamin d insufficiency in patients with Parkinson disease and Alzheimer disease.
M. Evatt (2008)
10.2105/AJPH.74.12.1374
Race and sex differences in hip fracture incidence.
M. Farmer (1984)
10.1007/s00223-003-0008-6
The Relationship Between COLI A1 Polymorphisms (Sp 1) and COLI A2 Polymorphisms (Eco R1 and Puv II) with Bone Mineral Density in Chinese Men and Women
E. Lau (2003)
10.1016/J.ANNEPIDEM.2003.08.005
Hip fractures and Alzheimer's disease in elderly institutionalized Canadians.
I. Weller (2004)
10.1007/s11914-012-0119-y
The Role of Diet in Osteoporosis Prevention and Management
S. Levis (2012)
Human interleukin-17. Arthritis Rheum
M Chabaud (1999)
Gene - environment interactions in the skeletal response to nutrition and exercise during growth . Optimizing Bone Mass and Strength . Karger Publishers
JP Bonjour (2007)
Novel polymorphism in the human Fos related antigen-1 gene is associated with bone mineral density in women from the UK. Paper presented at
O Albagha (2002)
10.1016/j.jneb.2017.05.346
Osteoporosis Knowledge and Health Beliefs Among Men in Midlife Years
O. Babatunde (2017)
10.1093/AJCN/44.2.287
Calcium supplements in the prevention of steroid-induced osteoporosis.
I. Reid (1986)
10.1093/OXFORDJOURNALS.AJE.A009024
Very low rates of hip fracture in Beijing, People's Republic of China the Beijing Osteoporosis Project.
L. Xu (1996)
10.1210/endo.143.6.8834
Divergent Effects of Selective Peroxisome Proliferator-Activated Receptor-γ2 Ligands on Adipocyte Versus Osteoblast Differentiation.
B. Lecka-Czernik (2002)
10.1172/JCI5703
IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis.
S. Kotake (1999)
10.1016/j.bone.2009.01.373
FRAX and its applications to clinical practice.
J. Kanis (2009)
10.1007/s001980050172
Forearm Fractures as Predictors of Subsequent Osteoporotic Fractures
M.-T. Cuddihy (1999)
UK Colles' Fracture Study. Incidence of distal forearm fracture in British men and women
T Oaposneill (2001)
10.1016/J.MATURITAS.2004.08.006
Association of the osteoprotegerin gene polymorphisms with bone mineral density in postmenopausal women.
B. Arko (2005)
10.1016/j.cytogfr.2012.06.003
The "bone morphogenic proteins" pathways in bone and joint diseases: translational perspectives from physiopathology to therapeutic targets.
E. Biver (2013)
10.1186/AR797
A review of anabolic therapies for osteoporosis
N. Lane (2003)
10.1172/JCI10942
Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men.
A. Falahati-Nini (2000)
10.2337/DIACARE.24.7.1192
Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women.
K. Nicodemus (2001)
10.1002/ART.10619
Missed opportunities in physician management of glucocorticoid-induced osteoporosis?
R. Ramsey-Goldman (2002)
10.1007/s00223-003-0023-7
Diabetes Mellitus: Does it Affect Bone?
A. Schwartz (2003)
10.1007/s002239900270
Effect of Tobacco Consumption on Bone Mineral Density in Healthy Young Males
N. Ortego-centeno (1997)
10.1002/JBMR.5650110718
Vitamin D receptor alleles, bone mineral density and turnover in premenopausal Japanese women
Akifumi Tokitan (1996)
10.1016/s0021-9258(18)48151-3
DNA sequences in the first intron of the human pro-alpha 1(I) collagen gene enhance transcription.
C. Rossouw (1987)
Vertebral Fractures and Mortality in Older Women
D. Kado (2017)
10.1007/s00702-009-0241-x
Blood biomarkers of osteoporosis in mild cognitive impairment and Alzheimer’s disease
C. Luckhaus (2009)
10.1038/nm1514
v-ATPase V0 subunit d2–deficient mice exhibit impaired osteoclast fusion and increased bone formation
Seoung-Hoon Lee (2006)
10.1210/EN.2003-1185
Ligand-selective dissociation of activation and internalization of the parathyroid hormone (PTH) receptor: conditional efficacy of PTH peptide fragments.
W. Sneddon (2004)
mass effects of a BMP 4 gene polymorphism in postmenopausal women
LR Babu (2005)
10.1158/1078-0432.CCR-06-0931
Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity
R. Coleman (2006)
10.1093/AJE/KWM106
Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture.
M. Janghorbani (2007)
Human interleukin - 17
M Chabaud (1999)
International Osteoporosis Foundation Committee of Scientific Advisors Working Group on Cancer-Induced Bone Disease. Cancer-associated bone disease
R Rizzoli (2013)
10.1038/NG1096-203
Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I α 1 gene
S. Grant (1996)
10.1359/jbmr.2000.15.11.2222
A TA Repeat Polymorphism in the Estrogen Receptor Gene Is Associated with Osteoporotic Fractures but Polymorphisms in the First Exon and Intron Are Not
B. Langdahl (2000)
10.1007/s00198-016-3762-9
Differences in bone quality and strength between Asian and Caucasian young men
A. Kepley (2016)
10.1073/PNAS.89.15.6665
Contribution of trans-acting factor alleles to normal physiological variability: vitamin D receptor gene polymorphism and circulating osteocalcin.
N. Morrison (1992)
10.2147/TCRM.S131945
Fracture risk in patients with type 2 diabetes mellitus and possible risk factors: a systematic review and meta-analysis
A. Moayeri (2017)
10.1021/BI00423A003
Characterization of the rat osteocalcin gene: stimulation of promoter activity by 1,25-dihydroxyvitamin D3.
K. Yoon (1988)
10.1007/BF00296650
Fracture of the distal forearm as a forecaster of subsequent hip fracture: A population-based cohort study with 24 years of follow-up
H. Mallmin (2004)
10.1111/j.1463-1326.2007.00710.x
Role of vitamin D in the pathogenesis of type 2 diabetes mellitus
X. Palomer (2008)
10.3892/ijmm.2011.697
Insulin-dependent diabetes mellitus decreases osteoblastogenesis associated with the inhibition of Wnt signaling through increased expression of Sost and Dkk1 and inhibition of Akt activation.
M. Hie (2011)
10.1017/S136898001200331X
Alcohol consumption and bone mineral density in elderly women.
Isolde Sommer (2013)
10.1007/s100380050132
Association of radial bone mineral density with CA repeat polymorphism at the interleukin 6 locus in postmenoposal Japanese women
K. Tsukamoto (1999)
10.1016/j.trsl.2011.12.004
Role of advanced glycation endproducts and glyoxalase I in diabetic peripheral sensory neuropathy.
M. Jack (2012)
10.1007/s00223-017-0369-x
Cancer Treatment and Bone Health
C. Handforth (2017)
10.1210/JC.2005-2017
Polymorphisms in the CLCN7 gene modulate bone density in postmenopausal women and in patients with autosomal dominant osteopetrosis type II.
U. Kornak (2006)
10.1023/B:REMD.0000032415.83124.20
Osteoporosis and Diabetes Mellitus
A. Inzerillo (2004)
loss in early postmenopausal women : a two - year randomized , placebo - controlled study
PD Delmas (1996)
Estrogen receptor α polymorphism as a genetic marker for bone loss, vertebral fractures and susceptibility to estrogen
小林 範子 (2002)
10.1074/jbc.M109.051557
RANKL-mediated Reactive Oxygen Species Pathway That Induces Long Lasting Ca2+ Oscillations Essential for Osteoclastogenesis*
M. S. Kim (2010)
10.1152/JAPPLPHYSIOL.00741.2003
Resistance exercise as a countermeasure to disuse-induced bone loss.
L. Shackelford (2004)
10.1507/ENDOCRJ.45.123
Vitamin D receptor genotype is associated with cortical bone loss in Japanese patients with primary hyperparathyroidism.
T. Kobayashi (1998)
10.1097/GRF.0b013e3182aa1daf
Osteoporosis risk factors and early life-style modifications to decrease disease burden in women.
M. Nachtigall (2013)
10.1111/j.0105-2896.2005.00324.x
The role of T lymphocytes in bone metabolism
M. Weitzmann (2005)
10.1006/BULM.1999.0146
Parathyroid hormone temporal effects on bone formation and resorption
M. H. Kroll (2000)
10.1056/NEJM199503233321202
Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group.
S. Cummings (1995)
10.1001/JAMA.289.1.76
Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001.
A. Mokdad (2003)
Estrogen replacement therapy and fractures in older women. Study of Osteoporotic Fractures Research Group.
J. Cauley (1995)
10.1007/BF03194342
Cytokines in the pathogenesis of osteoporosis
E. Romas (2010)
10.1007/s00223-003-0170-x
Estrogen Receptor β Dinucleotide (CA) Repeat Polymorphism is Significantly Associated with Bone Mineral Density in Postmenopausal Women
J. Scariano (2003)
10.1007/s00198-006-0304-x
The vertebral fracture cascade in osteoporosis: a review of aetiopathogenesis
A. Briggs (2006)
10.1210/JCEM.87.8.8750
Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial.
P. Delmas (2002)
10.1007/s00198-014-2879-y
Alcohol consumption and hip fracture risk
X. Zhang (2014)
10.1038/nm1538
Dickkopf-1 is a master regulator of joint remodeling
Danielle Diarra (2007)
10.1007/BF01623274
Radial and humeral fractures as predictors of subsequent hip, radial or humeral fractures in women, and their seasonal variation
J. Lauritzen (2005)
10.1002/14651858.CD009678.pub2
Nutritional interventions for survivors of childhood cancer.
Jennifer Cohen (2016)
Hyperglycemia activates JAK 2 signaling pathway in human failing myocytes via angiotensin II - mediated oxidative stress
A Modesti (2005)
10.1016/j.abb.2012.02.004
Vitamin D and osteoporosis-related fracture.
N. Binkley (2012)
10.1359/jbmr.1997.12.6.915
A Vitamin D Receptor Gene Polymorphism in the Translation Initiation Codon: Effect on Protein Activity and Relation to Bone Mineral Density in Japanese Women
H. Arai (1997)
Ethnic difference in osteoporosis-related phenotypes and its potential underlying genetic determination.
S. Lei (2006)
10.1007/s00774-004-0593-0
The prevalence of Apo E4 genotype and its relationship to bone mineral density in Hong Kong Chinese
Samuel Yeung Shan Wong (2004)
10.1136/bmj.310.6991.1357
Influence of vitamin D receptor genotype on bone mineral density in postmenopausal women: a twin study in Britain
T. Spector (1995)
10.1359/JBMR.1999.14.7.1175
Apolipoprotein E polymorphism: A new genetic marker of hip fracture risk--The Study of Osteoporotic Fractures.
J. Cauley (1999)
10.1046/j.1444-1586.2003.00065.x
Association of tumor necrosis factor receptor 1 gene polymorphism with bone mineral density
Shinjiro Hoshino (2003)
10.1016/S8756-3282(97)00178-6
Estrogen receptor gene polymorphism and bone mineral density at the lumbar spine of pre- and postmenopausal women.
H. Mizunuma (1997)
10.1007/s00223-016-0229-0
Obesity, Type 2 Diabetes and Bone in Adults
J. Walsh (2016)
10.1007/s00223-002-0019-8
A CAG Repeat Polymorphism in the Androgen Receptor Gene is Associated with Reduced Bone Mass and Increased Risk of Osteoporotic Fractures
B. Langdahl (2002)
10.1016/J.BONE.2004.12.005
Bone mass effects of a BMP4 gene polymorphism in postmenopausal women.
L. Ramesh Babu (2005)
10.1093/GERONA/61.5.495
Gender differences in functioning after hip fracture.
W. Hawkes (2006)
10.1677/JOE-07-0095
The emerging role of the fibroblast growth factor-23-klotho axis in renal regulation of phosphate homeostasis.
M. Razzaque (2007)
10.1210/EDRV.21.2.0395
Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis.
S. Manolagas (2000)
10.1016/j.gene.2012.10.041
Association between osteoporosis and polymorphisms of the bone Gla protein, estrogen receptor 1, collagen 1-A1 and calcitonin receptor genes in Turkish postmenopausal women.
S. Tural (2013)
10.1677/JOE.0.1710229
Estrogen receptor specificity in the regulation of the skeleton in female mice.
M. Lindberg (2001)
10.1038/ejhg.2011.245
Polymorphisms in the P2X7 receptor gene are associated with low lumbar spine bone mineral density and accelerated bone loss in post-menopausal women
Alison Gartland (2012)
10.1016/0092-8674(94)90131-7
Hydrogen peroxide mediates amyloid β protein toxicity
C. Behl (1994)
10.4239/wjd.v2.i3.41
Osteoporosis in diabetes mellitus: Possible cellular and molecular mechanisms.
Kannikar Wongdee (2011)
10.1002/1529-0131(200101)44:1<196::AID-ANR26>3.0.CO;2-5
A functional polymorphic variant in the interleukin-6 gene promoter associated with low bone resorption in postmenopausal women.
S. Ferrari (2001)
10.1007/s002230001160
Association of CTR and COLIA1 Alleles with BMD Values in Peri- and Postmenopausal Women
V. Braga (2000)
10.1016/S8756-3282(96)00219-0
Effects of two doses of tibolone on trabecular and cortical bone loss in early postmenopausal women: a two-year randomized, placebo-controlled study.
B. Berning (1996)
10.1080/07853890510011958
Bone mineral density, body height, and vitamin D receptor gene polymorphism in middle‐aged men
T. Remes (2005)
10.1074/JBC.M109683200
Matrix GLA Protein, a Regulatory Protein for Bone Morphogenetic Protein-2*
Amina F. Zebboudj (2002)
mineral density and osteoporotic fractures
M Miyao (2006)
10.1007/s001980200108
The Epidemiology of Corticosteroid-Induced Osteoporosis: a Meta-analysis
T. Staa (2002)
10.1136/bjo.2005.069591
Gremlin gene expression in bovine retinal pericytes exposed to elevated glucose
R. Kane (2005)
10.1210/JCEM.80.12.8530616
Calcium absorption on high and low calcium intakes in relation to vitamin D receptor genotype.
B. Dawson-Hughes (1995)
10.1002/JCLA.1036
Relation of polymorphism in the promotor region for the human osteocalcin gene to bone mineral density and occurrence of osteoporosis in postmenopausal Chinese women in Taiwan
H. Chen (2001)
10.1093/ageing/afq146
Hip fracture risk and subsequent mortality among Alzheimer's disease patients in the United Kingdom, 1988-2007.
N. Baker (2011)
10.1210/JCEM.83.3.4648
Human adrenocorticotropin-secreting pituitary adenomas show frequent loss of heterozygosity at the glucocorticoid receptor gene locus.
N. Huizenga (1998)
10.1016/j.bone.2006.04.029
T-1213C polymorphism of estrogen receptor beta is associated with low bone mineral density and osteoporotic fractures.
A. Kung (2006)
10.2169/internalmedicine.54.3673
Osteomalacia, severe thoracic deformities and respiratory failure in a young woman with anorexia nervosa.
Daisuke Watanabe (2015)
10.1002/jbmr.280
More forearm fractures among urban than rural women: The NOREPOS study based on the Tromsø study and the HUNT study
T. Omsland (2011)
10.1359/jbmr.2001.16.5.911
A Common Promoter Variant in the Cytochrome P450c17α (CYP17) Gene Is Associated with Bioavailable Testosterone Levels and Bone Size in Men
J. Zmuda (2001)
10.1002/ART.1780340908
Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis.
C. Chu (1991)
10.1128/MCB.24.10.4384-4394.2004
Sequential Activation of Phosphatidylinositol 3-Kinase, βPix, Rac1, and Nox1 in Growth Factor-Induced Production of H2O2
H. Park (2004)
10.1097/00005650-200104000-00009
Trends in Hormonal Management of Prostate Cancer:: A Population-Based Study in Ontario
S. Bondy (2001)
10.1038/ejcn.2014.231
A fruit, milk and whole grain dietary pattern is positively associated with bone mineral density in Korean healthy adults
S. Shin (2014)
10.1210/jc.2011-2186
Circulating levels of sclerostin are increased in patients with type 2 diabetes mellitus.
A. García-Martín (2012)
10.2353/AJPATH.2007.060834
Osteoclasts: what do they do and how do they do it?
S. Teitelbaum (2007)
10.1007/s00198-010-1319-x
Osteoporosis in inflammatory joint diseases
C. Roux (2010)
10.1007/s00774-003-0474-y
Association of vitamin D and estrogen receptor gene polymorphism with the effects of longterm hormone replacement therapy on bone mineral density
T. Kurabayashi (2003)
10.1111/j.1365-2265.2007.03162.x
Primary hyperparathyroidism and the skeleton
L. Mosekilde (2008)
10.1007/BF03343923
Association of a T262C transition in exon 1 of estrogen-receptor-α gene with skeletal responsiveness to estrogen in post-menopausal women
B. Ongphiphadhanakul (2001)
10.2337/DIACARE.22.7.1196
Bone mineral density in patients with type 1 and type 2 diabetes.
J. Tuominen (1999)
10.1185/03007990802352894
Modulatory effect of farnesyl pyrophosphate synthase (FDPS) rs2297480 polymorphism on the response to long-term amino-bisphosphonate treatment in postmenopausal osteoporosis.
F. Marini (2008)
10.1007/s00109-002-0348-0
Association of polymorphisms of the estrogen receptor α gene with bone mineral density of the femoral neck in elderly Japanese women
Y. Yamada (2002)
10.1074/jbc.M111.296228
Molecular Basis of Requirement of Receptor Activator of Nuclear Factor κB Signaling for Interleukin 1-mediated Osteoclastogenesis*
J. Jules (2012)
10.1136/ard.61.suppl_2.ii84
Bone destruction in arthritis
E. Gravallese (2002)
10.1172/JCI6730
Increased cortical bone mineral content but unchanged trabecular bone mineral density in female ERbeta(-/-) mice.
S. Windahl (1999)
10.1002/JBMR.5650090802
The diagnosis of osteoporosis
J. Kanis (1992)
10.1038/nrendo.2011.233
Bone, sweet bone—osteoporotic fractures in diabetes mellitus
C. Hamann (2012)
Fracture risk in androgen deprivation therapy: a Canadian population based analysis.
Yiu-Keung Lau (2009)
10.1172/JCI11685
Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone.
J. Zhang (2001)
10.1007/s00223-015-9966-8
Deteriorating Effect on Bone Metabolism and Microstructure by Passive Cigarette Smoking Through Dual Actions on Osteoblast and Osteoclast
C. Ko (2015)
Vitamin D receptor gene polymorphisms, bone mineral density and bone turnover: FokI genotype is related to postmenopausal bone mass.
K. Zajíčková (2002)
10.1002/ART.22117
Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis.
T. V. van Staa (2006)
10.1074/JBC.M909675199
Impaired Estrogen Sensitivity in Bone by Inhibiting Both Estrogen Receptor α and β Pathways*
S. Ogawa (2000)
10.1007/S11914-007-0027-8
Cancer-associated bone disease
S. Brown (2007)
10.1002/cbf.1668
Insulin stimulates osteoblast proliferation and differentiation through ERK and PI3K in MG‐63 cells
J. Yang (2010)
10.1210/JCEM.83.7.4971
Normal growth hormone secretory reserve in men with idiopathic osteoporosis and reduced circulating levels of insulin-like growth factor-I.
E. Kurland (1998)
10.1007/s00198-006-0172-4
An estimate of the worldwide prevalence and disability associated with osteoporotic fractures
O. Johnell (2006)
10.2174/138161208784139774
Role of advanced glycation end products in diabetic neuropathy.
K. Sugimoto (2008)
10.1056/NEJM198510173131602
Cigarette smoking, serum estrogens, and bone loss during hormone-replacement therapy early after menopause.
J. Jensen (1985)
10.1093/HMG/DDG176
Association of 5' estrogen receptor alpha gene polymorphisms with bone mineral density, vertebral bone area and fracture risk.
J. V. van Meurs (2003)
10.1371/journal.pone.0082806
Association between Estrogen Receptor α Gene (ESR1) PvuII (C/T) and XbaI (A/G) Polymorphisms and Hip Fracture Risk: Evidence from a Meta-Analysis
Li Tang (2013)
10.1002/JBMR.5650111204
The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal mexican‐American women
C. Gross (1996)
10.1359/jbmr.2001.16.4.758
Genetic Control of Bone Density and Turnover: Role of the Collagen 1α1, Estrogen Receptor, and Vitamin D Receptor Genes
M. A. Brown (2001)
10.1093/RHEUMATOLOGY/40.1.48
Evidence of association and linkage disequilibrium between a novel polymorphism in the transforming growth factor beta 1 gene and hip bone mineral density: a study of female twins.
R. Keen (2001)
10.1007/s002239900603
Association Study of Parathyroid Hormone Gene Polymorphism and Bone Mineral Density in Japanese Postmenopausal Women
T. Hosoi (1999)
10.1016/j.bone.2015.05.002
Relationships between bone geometry, volumetric bone mineral density and bone microarchitecture of the distal radius and tibia with alcohol consumption.
J. Paccou (2015)
10.1007/BF01880454
Consensus development conference: Prophylaxis and treatment of osteoporosis
R. Bouillon (2005)
10.1007/BF02555885
Alpha2-HS glycoprotein phenotypes and quantitative hormone and bone measures in postmenopausal women
J. Eichner (2007)
10.1007/PL00005835
Association of Bone Mineral Density with Polymorphism of the Human Calcium-Sensing Receptor Locus
K. Tsukamoto (2000)
10.1002/biof.1016
Endothelial progenitor cells in diabetes mellitus
L. Menegazzo (2012)
10.1007/BF01321155
Hip fracture mortality and morbidity in Switzerland and Japan: A cross-cultural comparison
N. Fujiwara (2005)
10.1016/S1043-2760(97)00066-0
Vitamin D and hematopoiesis
C. Bunce (1997)
10.1093/RHEUMATOLOGY/40.12.1375
Prevalence of vertebral deformities and symptomatic vertebral fractures in corticosteroid treated patients with rheumatoid arthritis.
R. D. de Nijs (2001)
10.1016/S8756-3282(98)00109-4
Allelic variation at the interleukin-1 receptor antagonist gene is associated with early postmenopausal bone loss at the spine.
R. Keen (1998)
10.1186/1478-7954-8-29
Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence
J. P. Boyle (2010)
10.1016/8756-3282(93)90341-7
Hip fractures: a worldwide problem today and tomorrow.
L. J. Melton (1993)
10.1128/MCB.25.12.4946-4955.2005
Reduced Affinity to and Inhibition by DKK1 Form a Common Mechanism by Which High Bone Mass-Associated Missense Mutations in LRP5 Affect Canonical Wnt Signaling
Minrong Ai (2005)
10.1016/S0925-4439(99)00007-1
Vitamin D receptor 3'-untranslated region polymorphisms: lack of effect on mRNA stability.
L. Durrin (1999)
10.1007/s11999-011-1863-5
Defining Ethnic and Racial Differences in Osteoporosis and Fragility Fractures
J. Cauley (2011)
10.1007/BF00425868
Genetics of osteoporosis
Carmelo E. Fiore (1994)
10.1007/BF02499894
Polymorphisms of the interleukin-6 gene are associated with bone mineral density
R. Murray (2006)
10.1007/s12603-013-0348-5
A cross sectional study to examine the association between dietary patterns and cognitive impairment in older Chinese people in Hong Kong
R. Chan (2013)
10.1359/jbmr.2003.18.6.960
High Bone Mass in Mice Expressing a Mutant LRP5 Gene
Philip Babij (2003)
10.1016/s0021-9258(18)89556-4
Fine structural analysis of the human pro-alpha 1 (I) collagen gene. Promoter structure, AluI repeats, and polymorphic transcripts.
M. L. Chu (1985)
10.1136/ard.54.1.49
Rheumatoid arthritis, corticosteroid therapy and hip fracture.
C. Cooper (1995)
10.4168/aair.2011.3.4.251
The Relationship Between Serum 25 Hydroxy Vitamin D Levels and Asthma in Children
S. Alyasin (2011)
10.1359/jbmr.2001.16.1.128
Estrogen Receptor α Gene Polymorphisms and Bone Mineral Density: Haplotype Analysis in Women from the United Kingdom
O. Albagha (2001)
10.1111/j.1532-5415.1994.tb06547.x
TYPE OF FALL AND RISK OF HIP AND WRIST FRACTURES: THE STUDY OF OSTEOPOROTIC FRACTURES
P. Drinka (1994)
10.1038/367284A0
Prediction of bone density from vitamin D receptor alleles
N. Morrison (1994)
10.1016/S0006-291X(89)80062-2
Estradiol stimulates in vitro the secretion of insulin-like growth factors by the clonal osteoblastic cell line, UMR106.
T. Gray (1989)
Bone Mineral Status Response to Aerobic Versus Resistance Exercise Training in Postmenopausal Women
M. H. S. Al-dahr (2013)
10.2337/DIABETES.54.2.394
Hyperglycemia activates JAK2 signaling pathway in human failing myocytes via angiotensin II-mediated oxidative stress.
A. Modesti (2005)
10.1016/j.vhri.2015.09.005
Lifestyle-Related Metabolic Disorders, Osteoporosis, and Fracture Risk in Asia: A Systematic Review.
T. Sugimoto (2016)
10.1111/J.1753-4887.2007.TB00353.X
Osteoporosis and inflammation.
G. Mundy (2007)
10.1016/0960-0760(95)00031-T
Aromatase in bone cell: Association with osteoporosis in postmenopausal women
H. Nawata (1995)
10.1007/s00223-009-9296-9
Enhancement of Absolute Fracture Risk Prognosis with Genetic Marker: The Collagen I Alpha 1 Gene
Bich N. H. Tran (2009)
10.1128/MCB.13.6.3359
Sequences within the last intron function in RNA 3'-end formation in cultured cells.
D. Nešić (1993)
10.1007/s00198-004-1704-4
Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism is associated with osteoporotic vertebral fractures, but is a weak predictor of BMD
Morten M. Villadsen (2004)
10.1111/j.1468-1331.2010.03103.x
BsmI vitamin D receptor’s polymorphism and bone mineral density in men and premenopausal women on long‐term antiepileptic therapy
I. Lambrinoudaki (2011)
10.1186/ar67
Mechanisms of bone loss in inflammatory arthritis: diagnosis and therapeutic implications
S. Goldring (2000)
loss in women with ER ( + ) breast cancer
JM Zmuda (2013)
10.1111/J.1523-1755.2005.00587.X
Coordinated control of renal Ca(2+) transport proteins by parathyroid hormone.
Monique van Abel (2005)
Novel polymorphism in the human Fos related antigen-1 gene is associated with bone mineral density in women from the UK
O Albagha (2002)
Metastasis to bone: causes, consequences and therapeutic opportunities
GR Mundy (2002)
10.7326/0003-4819-122-1-199501010-00002
Estrogen Replacement Therapy and Fractures in Older Women
J. Cauley (1995)
Fisetin inhibits hyperglycemiainduced proinflammatory cytokine production by epigenetic mechanisms. Evid Based Complement Alternat Med
H J Kim (2012)
10.1007/BF01623184
Hip fractures in the elderly: A world-wide projection
C. Cooper (2005)



This paper is referenced by
10.1080/13697137.2019.1640195
Association between rs12742784 polymorphism and hip fracture, bone mineral density, and EPHB2 mRNA expression levels in elderly Chinese women
Z. Ruan (2019)
10.1155/2020/8836583
Woman with Pregnancy and Lactation-Associated Osteoporosis (PLO)
Nasrin Bazgir (2020)
10.3390/jcm9103253
Helicobacter pylori Related Diseases and Osteoporotic Fractures (Narrative Review)
L. Fisher (2020)
10.3390/nu12082394
Role of Vitamin C in Osteoporosis Development and Treatment—A Literature Review
Olga Brzezińska (2020)
10.3390/ijerph17061862
How Physical Activity across the Lifespan Can Reduce the Impact of Bone Ageing: A Literature Review
M. F. Faienza (2020)
10.1097/MD.0000000000019120
Network and pathway-based analyses of genes associated with osteoporosis
Huijie Gu (2020)
10.1002/jbm4.10488
Bone Aging, Cellular Senescence, and Osteoporosis
R. Pignolo (2021)
10.1024/0300-9831/a000621
Prudent and traditional dietary patterns are positively and negatively associated with bone mineral density in Iranian adults, respectively.
A. Najafi (2020)
10.1016/j.matpr.2020.02.833
Bone fracture risk: Density and microarchitecture qualification
F. Cosmi (2020)
10.1016/j.jep.2019.111977
Integrated pathological cell fishing and network pharmacology approach to investigate main active components of Er-Xian decotion for treating osteoporosis.
N. Wang (2019)
10.1097/MPA.0000000000001538
The Risk of Vitamin D Deficiency, Osteoporosis, and Fractures in Acute Pancreatitis
Mohannad Abou Saleh (2020)
10.1007/s00198-020-05476-z
Effects of isoflavone interventions on bone mineral density in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials
K. Sansai (2020)
10.1177/0300060520903868
Salusin-β is superior to salusin-α as a marker for evaluating coronary atherosclerosis
Yuxue Wang (2020)
10.1016/j.jmst.2020.10.055
One-step electrodeposition synthesis of bisphosphonate loaded magnesium implant: A strategy to modulate drug release for osteoporotic fracture healing
Peng Wan (2021)
10.1016/j.jocd.2020.02.001
Salivary Content Might be Associated With Skeletal Status in Postmenopausal Women: SilesiaOsteoActive Study Results.
E. Tabor (2020)
10.1016/j.afos.2020.08.003
Is ankle fracture related to low bone mineral density and subsequent fracture? A systematic review
Atiporn Therdyothin (2020)
10.1007/s11357-020-00251-8
Handgrip strength—a risk indicator for future fractures in the general population: findings from a prospective study and meta-analysis of 19 prospective cohort studies
S. Kunutsor (2020)
10.2147/JIR.S203590
Circulatory pattern of cytokines, adipokines and bone markers in postmenopausal women with low BMD
F. Azizieh (2019)
10.1101/2020.11.19.390757
Impact of Chrysin on Vitamin D and Bone Health - Preclinical Studies
Siva Swapna Kasarla (2020)
10.3390/ijms21103679
Molecular Basis of Bone Aging
A. Corrado (2020)
10.3390/nu12082203
A Dairy Product to Reconstitute Enriched with Bioactive Nutrients Stops Bone Loss in High-Risk Menopausal Women without Pharmacological Treatment
M. Morato-Martínez (2020)
10.1016/j.bone.2019.06.007
Thoracic vertebral fractures and hyperkyphosis in elderly patients with end-stage kidney disease; do these patients have different clinical outcomes?
N. Goto (2019)
10.1093/ibd/izz254
Injury Characteristics and Outcomes of Patients With Inflammatory Bowel Disease After Trauma: A Propensity Score Matched Analysis.
Bryce E. Haac (2019)
10.3390/nu12103210
Green Tomato Extract Prevents Bone Loss in Ovariectomized Rats, a Model of Osteoporosis
F. S. Nirmala (2020)
10.1136/annrheumdis-2020-218906
Response to: 'Correspondence on 'Systemic evaluation of the relationship between psoriasis, psoriatic arthritis and osteoporosis: observational and Mendelian randomisation study' by Lee.
J. Xia (2020)
10.2169/internalmedicine.3906-19
Association of Bone Metabolism with Fatty Liver Disease in the Elderly in Japan: A Community-based Study
K. Mikami (2020)
10.1016/j.rcreue.2019.10.003
Osteoporosis in men of the endocrinology outpatient clinic in Manizales city, Colombia
Antonella Sánchez Lozada (2019)
10.3892/etm.2019.7849
MicroRNA-135a-5p is involved in osteoporosis progression through regulation of osteogenic differentiation by targeting RUNX2
X. Shi (2019)
10.24144/2077-6594.3.2020.208618
Analysis of selected risk factors of osteoporosis
J. Raková (2020)
10.1007/s11657-020-00850-0
Racial differences and factors associated with low femoral neck bone mineral density: an analysis of NHANES 2005–2014 data
Xiao-yun Zheng (2021)
10.1007/s00223-019-00625-x
Schizophrenia, Bipolar Disorder, and Alzheimer’s Disease are not Causal Factors of Bone Mineral Density: A Mendelian Randomization Analysis
Z. Cui (2019)
10.1111/acel.13301
Role of sirtuins in bone biology: Potential implications for novel therapeutic strategies for osteoporosis
Qiangqiang Li (2021)
See more
Semantic Scholar Logo Some data provided by SemanticScholar